 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|---|
|
   |
| Medical Marijuana Incorporated News Alert and 2016 Recap |
|
 Hot Stock to Watch |
Company: Medical Marijuana, Inc. (Pink Sheets: MJNA)
|
Last:
Price: 0.176
Change (%): + 0.003 (1.72)
Volume: 13,213,907 |
 |
Medical Marijuana, Inc.'s Year in Review: 2016 Vote for Cannabis Reform in 8 States, International Expansion Highlights Historic Year
Company Releases Recap Report of Activities in 2016 and Announces Excitement for Coming Year
SAN DIEGO, CA-(Marketwired - December 28, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced the release of a 2016 business year in review posted to their website HERE. As you can view HERE, Medical Marijuana, Inc. has long been “A Company of Firsts.” 2016 continued to show the company’s progress with many firsts including; receiving the first-ever import permit from the Mexican federal government, receiving the world’s first patented cannabinoid controlled-release chewing gum and becoming the first-ever DEA permit granted to a US-based company to import pharmaceutical grade cannabidiol. Additionally, they participated in first-ever events like the Doctors Symposium in Mexico, ExpoMede Weed in Medellin, Colombia and Genesis in San Diego.
This recap highlights various exciting business activities and developments within Medical Marijuana, Inc.’s diverse investments and portfolio companies throughout the year and shares the enthusiasm for the future of the Company. The Company began the year with the momentum started in 2015 with legislative reform in the sector and a growing need for access to hemp products throughout the U.S. and around the world.
Continue Reading
|
Medical Marijuana, Inc. Featured in L.A. Weekly Profile Story Covering Historic Export Agreements With Mexico, Other Latin American Nations
Article Features Unique Nature of Export Agreement of Cannabis-Related Products From Southern California to Latin America
SAN DIEGO, CA-(Marketwired - December 29, 2016) - Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company, its subsidiary HempMeds® Mexico and its products were featured in an L.A. Weekly article focused on the first-ever import permit granted by Mexico for the cannabidiol (CBD) oil product Real Scientific Hemp Oil-X™ (RSHO-X™).
The Dec. 23, 2016, article titled “Mexico Begins Importing Medical Marijuana As Views on Therapeutic Cannabis Evolve” states, “The California-based company’s partnership with Mexico - an ally of particular interest thanks to cultural and historical ties that date back centuries - was solidified earlier this year when COFEPRIS, the Mexican health department, approved the country’s first permit allowing the import of hemp-based CBD oil across its border.” The article goes on to describe how the company worked with attorneys representing families - who then worked with COFEPRIS to develop a “THC-free” version, called RSHO-X™.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
